Literature DB >> 35311588

Purification and Identification of Natural Inhibitors of Protein Arginine Methyltransferases from Plants.

Zhengxin Wang1, Ling Xiong1, Quanbo Xiong2.   

Abstract

Protein arginine methyltransferase (PRMT) enzymes catalyze posttranslational modifications of target proteins and are often upregulated in human cancers. In this study, we purified two chemical compounds from seeds of Foeniculum vulgare based on their ability to inhibit the enzymatic activity of PRMT5. These two compounds were identified as Pheophorbide a (PPBa) and Pheophorbide b (PPBb), two breakdown products of chlorophyll. PPBa and PPBb inhibited the enzymatic activity of both Type I and Type II PRMTs with IC50 values at sub micromole concentrations, inhibited the arginine methylation of histones in cells, and suppressed proliferation of prostate cancer cells. Molecular docking results predicted that PPBa binds to an allosteric site in the PRMT5 structure with a high affinity (ΔG = -9.0 kcal/mol) via hydrogen bond, ionic, and π-π stacking interactions with amino acid residues in PRMT5. Another group of natural compounds referred to as protoporphyrins and sharing structural similarity with pheophorbide also inhibited the PRMT enzymatic activity. This study is the first report on the PRMT-inhibitory activity of the tetrapyrrole macrocycles and provides useful information regarding the application of these compounds as natural therapeutic reagents for cancer prevention and treatment.

Entities:  

Keywords:  natural compounds; pheophorbide; protein arginine methyltransferase inhibitors; protoporphyrin; tetrapyrrole macrocycle

Mesh:

Substances:

Year:  2022        PMID: 35311588      PMCID: PMC9022574          DOI: 10.1128/mcb.00523-21

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   5.069


  51 in total

1.  The essential role of WD repeat domain 77 in prostate tumor initiation induced by Pten loss.

Authors:  Deon O'Bryant; Zhengxin Wang
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

Review 2.  Recent progress in developing selective inhibitors of protein methyltransferases.

Authors:  H Ümit Kaniskan; Jian Jin
Journal:  Curr Opin Chem Biol       Date:  2017-06-26       Impact factor: 8.822

3.  2 The family of protein arginine metkyltransferases.

Authors:  Mark T Bedford
Journal:  Enzymes       Date:  2007-06-04

4.  Evaluation of two biosynthetic pathways to delta-aminolevulinic acid in Euglena gracilis.

Authors:  Katsumi Iida; Ippei Mimura; Masahiro Kajiwara
Journal:  Eur J Biochem       Date:  2002-01

Review 5.  Chlorophyll breakdown in higher plants.

Authors:  Stefan Hörtensteiner; Bernhard Kräutler
Journal:  Biochim Biophys Acta       Date:  2010-12-16

Review 6.  Evolutionarily conserved protein arginine methyltransferases in non-mammalian animal systems.

Authors:  Yi-Chun Wang; Chuan Li
Journal:  FEBS J       Date:  2012-02-10       Impact factor: 5.542

Review 7.  Photodynamic therapy for cancer: Role of natural products.

Authors:  Behzad Mansoori; Ali Mohammadi; Mohammad Amin Doustvandi; Fatemeh Mohammadnejad; Farzin Kamari; Morten F Gjerstorff; Behzad Baradaran; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2019-05-04       Impact factor: 3.631

8.  CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features.

Authors:  Rania Elakoum; Guillaume Gauchotte; Abderrahim Oussalah; Marie-Pierre Wissler; Christelle Clément-Duchêne; Jean-Michel Vignaud; Jean-Louis Guéant; Farès Namour
Journal:  Biochimie       Date:  2013-11-06       Impact factor: 4.079

9.  The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.

Authors:  S S Tarighat; R Santhanam; D Frankhouser; H S Radomska; H Lai; M Anghelina; H Wang; X Huang; L Alinari; A Walker; M A Caligiuri; C M Croce; L Li; R Garzon; C Li; R A Baiocchi; G Marcucci
Journal:  Leukemia       Date:  2015-11-05       Impact factor: 11.528

10.  Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity.

Authors:  Gui-Mei Kong; Min Yu; Zhongping Gu; Zhi Chen; Rui-Ming Xu; Deon O'Bryant; Zhengxin Wang
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.